Vanguard Group’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Vanguard Group’s Portfolio JNCE Stock Details JNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,107,305	Closed	-$3.9M	–	4616
2023 Q1	$3.9M	Buy	2,107,305 +474,127	+29%	+$877K	﹤0.01%	3418
2022 Q4	$1.81M	Buy	1,633,178 +7,321	+0.5%	+$8.13K	﹤0.01%	3700
2022 Q3	$3.8M	Buy	1,625,857 +22,883	+1%	+$53.5K	﹤0.01%	3465
2022 Q2	$4.86M	Sell	1,602,974 -10,531	-0.7%	-$31.9K	﹤0.01%	3392
2022 Q1	$11M	Buy	1,613,505 +21,473	+1%	+$146K	﹤0.01%	3102
2021 Q4	$13.3M	Buy	1,592,032 +148,603	+10%	+$1.24M	﹤0.01%	3067
2021 Q3	$10.7M	Buy	1,443,429 +36,604	+3%	+$272K	﹤0.01%	3201
2021 Q2	$9.57M	Buy	1,406,825 +46,060	+3%	+$313K	﹤0.01%	3227
2021 Q1	$14M	Buy	1,360,765 +459,705	+51%	+$4.72M	﹤0.01%	2971
2020 Q4	$6.31M	Sell	901,060 -1,932	-0.2%	-$13.5K	﹤0.01%	3246
2020 Q3	$7.37M	Sell	902,992 -79,871	-8%	-$652K	﹤0.01%	2954
2020 Q2	$6.78M	Sell	982,863 -28,962	-3%	-$200K	﹤0.01%	2946
2020 Q1	$4.81M	Buy	1,011,825 +72,287	+8%	+$343K	﹤0.01%	2990
2019 Q4	$8.2M	Buy	939,538 +74,850	+9%	+$653K	﹤0.01%	2952
2019 Q3	$2.88M	Buy	864,688 +64,538	+8%	+$215K	﹤0.01%	3323
2019 Q2	$3.96M	Buy	800,150 +188,540	+31%	+$933K	﹤0.01%	3249
2019 Q1	$3.79M	Buy	611,610 +133,739	+28%	+$829K	﹤0.01%	3234
2018 Q4	$1.61M	Sell	477,871 -298,145	-38%	-$1M	﹤0.01%	3438
2018 Q3	$5.05M	Buy	776,016 +41,945	+6%	+$273K	﹤0.01%	3236
2018 Q2	$5.62M	Buy	734,071 +128,000	+21%	+$980K	﹤0.01%	3173
2018 Q1	$13.5M	Sell	606,071 -56,861	-9%	-$1.27M	﹤0.01%	2667
2017 Q4	$8.45M	Buy	662,932 +83,772	+14%	+$1.07M	﹤0.01%	2897
2017 Q3	$9.02M	Buy	579,160 +324,100	+127%	+$5.05M	﹤0.01%	2858
2017 Q2	$3.58M	Buy	255,060 +141,096	+124%	+$1.98M	﹤0.01%	3204
2017 Q1	$2.51M	Buy	+113,964	New	+$2.51M	﹤0.01%	3311